Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.3876
+0.00451.17%
Post-market: 0.3701-0.0175-4.51%19:52 EDT
Volume:559.43K
Turnover:216.93K
Market Cap:8.36M
PE:-0.33
High:0.4090
Open:0.3600
Low:0.3600
Close:0.3831
52wk High:2.75
52wk Low:0.1620
Shares:21.57M
Float Shares:17.83M
Volume Ratio:0.52
T/O Rate:3.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1720
EPS(LYR):-2.1664
ROE:-95.10%
ROA:-47.95%
PB:0.67
PE(LYR):-0.18

Loading ...

Company Profile

Company Name:
Mangoceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
3
Office Location:
17130 N. Dallas Parkway,Suite 240,Dallas,Texas,United States
Zip Code:
75248
Fax:
- -
Introduction:
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Directors

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Alex. P. Hamilton
Director
Kenny Myers
Director
Lorraine D'Alessio
Director

Shareholders

Name
Position
Jacob D. Cohen
Chairman and Chief Executive Officer
Eugene M. Johnston
Chief Financial Officer